Regeneron Pharmaceuticals (REGN) Stock Valuation: P/E Ratio and Intrinsic Value
Regeneron Pharmaceuticals share price
| Price (USD) | 927.89 |
|---|---|
| Price date | 2026-10-31 |
| Market capitalization | 93.84 USD bn |
Annual and quarterly filings: SEC EDGAR – Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals stock expensive or cheap? This page shows the price-earnings ratio of Regeneron Pharmaceuticals for the last fiscal years, the current share price, and beta and volatility as risk measures. Earnings figures come from the company's published filings.
How the Regeneron Pharmaceuticals P/E ratio is calculated
The price-earnings ratio divides the share price by earnings per share. On this page the ratio is shown per fiscal year, so you can see whether today's valuation of Regeneron Pharmaceuticals is above or below its own history. Beta and volatility indicate how strongly the share moves compared with the overall market.
Frequently asked questions about Regeneron Pharmaceuticals
What is the REGN P/E ratio?
The P/E ratio divides the Regeneron Pharmaceuticals share price by earnings per share. This page shows the ratio for each of the last fiscal years, so the current valuation of REGN can be compared with its own history.
Is Regeneron Pharmaceuticals stock overvalued or undervalued?
There is no single answer. A useful check is whether the current P/E of REGN is above or below its multi-year average and how earnings, margins and revenue are developing. This page shows all of these figures from the published filings.
How can I estimate the intrinsic value of Regeneron Pharmaceuticals?
An intrinsic value estimate needs earnings or free cash flow, a growth assumption and a discount rate. This page provides the reported earnings basis, margins and the valuation history of REGN as the starting point.